|
|
|
Volumn 23, Issue 3 SUPPL. 7, 1996, Pages 15-18
|
|
Ifosfamide-based chemotherapy for non-small cell lung cancer: Phase I/II studies at the University of Chicago
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
MITOMYCIN;
NAVELBINE;
PACLITAXEL;
VINCA ALKALOID;
ADULT;
AGED;
ARTICLE;
BONE MARROW TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
UNIVERSITY HOSPITAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PALLIATIVE CARE;
VINBLASTINE;
|
|
EID: 0029739191
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
